World leading stem cell research and innovation.

BHI Therapeutic Sciences is pioneering ethical, effective, safe and affordable stem cell treatment therapies utilizing cord blood stem cells.

The

Problem

The

Solution


Stem Cell Therapy

Stem cells are a special kind of cell that can be used to regenerate the human body without drugs or surgery, treating the leading diseases and injuries shortening our life spans and causing millions of people to live in chronic pain. BHI Therapeutic Sciences is pioneering ethical, effective, safe and affordable stem cell treatment therapies utilizing cord blood stem cells (those that are harvesting from an umbilical cord in the case of a C-Section, bringing no injury or risk to mother or baby).

The

Opportunity


TEXAS HB 810

Texas House Bill (HB 810) on stem cell therapy passed in the Texas state legislature and became law, allowing patients suffering from debilitating and incurable diseases to access innovative stem cell therapies and expanded clinical trials.

BHI Therapeutic Sciences is opening a stem cell treatment facility in Houston, having treated thousands of patients around the world with stem cell therapy.

Contact BHI Therapeutic Sciences


BHI Therapeutic Sciences is bringing the miracle of life saving stem cell treatments to the world, and you can help. Thanks to new laws that allow anyone in the general public to invest in new and emerging companies, you can invest in BHI Therapeutic Sciences. Sign up here and be among the first to know of developments with stem cell therapy and the opening of our clinic in Texas.


BHI Therapeutic Sciences is "testing the waters" for a possible offering of securities under Regulation A of the JOBS act. No money or other consideration is being solicited by the company at this time, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the qualification date. If you indicate interest, your indication of interest involves no obligation or commitment of any kind. If an offering statement has been filed, you may obtain a copy of the most recent version of the preliminary offering circular from Kendall Almerico at Kendall A. Almerico PA, 1440 G Street NW, Washington DC 20005 or by e-mailing info@bankroll.ventures.
Scroll Up